EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria

Ida Wilkens iD, Johanne Heine, Viktoria C Ruf, Yaroslau Compta, Laura Molina Porcel, Claire Troakes, Albert Vamanu, Sophia Downes, David Irwin, Jesse Cohen iD, Edward B Lee, Christer Nilsson und 16 weitere

Movement Disorders · 2024

DOI: 10.1002/mds.29879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2024. Verfasst von Ida Wilkens und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München, Munich, Germany. Hauptthemen laut MEDLINE: Multiple System Atrophy, Parkinson Disease, Magnetic Resonance Imaging. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, Deutsche Gesellschaft für Parkinson und Bewegungsstörungen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multiple system atrophy is a neurodegenerative disease with α‐synuclein aggregation in glial cytoplasmic inclusions, leading to dysautonomia, parkinsonism, and cerebellar ataxia.

Objective

The aim of this study was to validate the accuracy of the International Parkinson and Movement Disorder Society Multiple System Atrophy clinical diagnostic criteria, particularly considering the impact of the newly introduced brain magnetic resonance imaging (MRI) markers.

Methods

Diagnostic accuracy of the clinical diagnostic criteria for multiple system atrophy was estimated retrospectively in autopsy‐confirmed patients with multiple system atrophy, Parkinson's disease, progressive supranuclear palsy, and corticobasal degeneration.

Results

We identified a total of 240 patients. Sensitivity of the clinically probable criteria was moderate at symptom onset but improved with disease duration (year 1: 9%, year 3: 39%, final ante mortem record: 77%), whereas their specificity remained consistently high (99%–100% throughout). Sensitivity of the clinically established criteria was low during the first 3 years (1%–9%), with mild improvement at the final ante mortem record (22%), whereas specificity remained high (99%–100% throughout). When MRI features were excluded from the clinically established criteria, their sensitivity increased considerably (year 1: 3%, year 3: 22%, final ante mortem record: 48%), and their specificity was not compromised (99%–100% throughout).

Conclusions

The International Parkinson and Movement Disorder Society multiple system atrophy diagnostic criteria showed consistently high specificity and low to moderate sensitivity throughout the disease course. The MRI markers for the clinically established criteria reduced their sensitivity without improving specificity. Combining clinically probable and clinically established criteria, but disregarding MRI features, yielded the best sensitivity with excellent specificity and may be most appropriate to select patients for therapeutic trials. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple System AtrophyParkinson DiseaseMagnetic Resonance ImagingHumansFemaleMaleAgedMiddle AgedRetrospective StudiesSupranuclear Palsy, ProgressiveSensitivity and SpecificityBrainAged, 80 and over

Stichwörter der Autor:innen

MRIautopsy‐confirmedbrain magnetic resonance imagingmultiple system atrophy

Autor:innen und Institutionen

  • Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München, Munich, Germany.
  • Department of Neurology, Hannover Medical School, Hanover, Germany.
  • Center for Neuropathology and Prion Research, Faculty of Medicine, LMU Munich, Munich, Germany.
  • Movement Disorders Unit, Neurology Service, Institut Clínic de Neurociències, Hospital Clínic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Catalonia, Spain.
  • Neurology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain.
  • Basic and Clinical Neuroscience Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

ORCID-Profile: Ida Wilkens, Jesse Cohen, Sabrina Katzdobler, Alex Pantelyat, Nathaniel Bendahan, Günter Höglinger, Franziska Hopfner

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • Deutsche Gesellschaft für Parkinson und Bewegungsstörungen

Zitieren

APA

Wilkens, I., Heine, J., Ruf, V. C., Compta, Y., Porcel, L. M., Troakes, C., Vamanu, A., Downes, S., Irwin, D., Cohen, J., Lee, E. B., Nilsson, C., Englund, E., Nemati, M., Katzdobler, S., Levin, J., Pantelyat, A., Seemiller, J., Berger, S., …, & Hopfner, F. (2024). Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria. Movement Disorders. https://doi.org/10.1002/mds.29879

Vancouver

Wilkens I, Heine J, Ruf VC, Compta Y, Porcel LM, Troakes C, et al. Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria. Movement Disorders. 2024. doi:10.1002/mds.29879

BibTeX
@article{Wilkens2024,
  author = {Wilkens, Ida and Heine, Johanne and Ruf, Viktoria C and Compta, Yaroslau and Porcel, Laura Molina and Troakes, Claire and Vamanu, Albert and Downes, Sophia and Irwin, David and Cohen, Jesse and Lee, Edward B and Nilsson, Christer and Englund, Elisabet and Nemati, Mojtaba and Katzdobler, Sabrina and Levin, Johannes and Pantelyat, Alex and Seemiller, Joseph and Berger, Stephen and van Swieten, John and Dopper, Elise and Rozenmuller, Annemieke and Kovacs, Gabor G and Bendahan, Nathaniel and Lang, Anthony E and Herms, Jochen and Höglinger, Günter and Hopfner, Franziska},
  title = {Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria},
  journal = {Movement Disorders},
  year = {2024},
  doi = {10.1002/mds.29879}
}
Kostenlos starten →